These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 151476)

  • 1. Somatostatin in the treatment of patients with extra-pyramidal disorders and patients with EEG abnormalities.
    Dupont E; Hansen AP; Juul-Jensen P; Lundbaek K; Magnussen I; de Fine Olivarius B
    Acta Neurol Scand; 1978 Jun; 57(6):488-93. PubMed ID: 151476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of extrapyramidal movement disorders.
    Klawans HL
    Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advances in the studies of the pathogenesis, treatment and prevention of genetically determined diseases of the extrapyramidal tracts].
    Wald I; Markowa J; Kulczycki J
    Neurol Neurochir Pol; 1988; 22(1):1-4. PubMed ID: 2967922
    [No Abstract]   [Full Text] [Related]  

  • 4. [Basis, clinical picture and therapy of diseases of the extrapyramidal-motoric system (EPMS)].
    Völler GW; Deze J
    Z Allgemeinmed; 1975 Mar; 51(8):353-73. PubMed ID: 1094755
    [No Abstract]   [Full Text] [Related]  

  • 5. [Peptide neurotransmitters and extrapyramidal disorders].
    Tan MX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):246-7. PubMed ID: 2416519
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
    Destee A
    LARC Med; 1984 Feb; 4(2):107-11. PubMed ID: 6232436
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters.
    Meldrum B
    Clin Sci (Lond); 1985 Feb; 68(2):113-22. PubMed ID: 2857118
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with memantine in the treatment of severe spastic and extrapyramidal movement disorders in combination with stereotaxic surgery].
    Mundinger F; Milios E
    Nervenarzt; 1985 Feb; 56(2):106-9. PubMed ID: 3885059
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
    Braun A; Mouradian MM; Mohr E; Fabbrini G; Chase TN
    J Neurol Neurosurg Psychiatry; 1989 May; 52(5):631-5. PubMed ID: 2567345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involuntary movement disorders.
    Still CN
    Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutics of disordered movement.
    Sears ES
    Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenomenology of the most important pyramidal and extrapyramidal motoric syndromes. Indications for surgery and results. I].
    Mundinger F
    Z Allgemeinmed; 1974 Jun; 50(18):827-37. PubMed ID: 4277897
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.
    Jankovic J
    Ann Neurol; 1982 Jan; 11(1):41-7. PubMed ID: 6460467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflex recovery curves in extrapyramidal disorders.
    Sax DS; Johnson TL; Cooper IS
    Adv Neurol; 1976; 14():285-96. PubMed ID: 133596
    [No Abstract]   [Full Text] [Related]  

  • 15. The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
    Papeschi R; Molina-Negro P; Sourkes TL; Erba G
    Neurology; 1972 Nov; 22(11):1151-9. PubMed ID: 4263829
    [No Abstract]   [Full Text] [Related]  

  • 16. [Syndrome involving the extrapyramidal motor systems and their drug treatment].
    Soyka D
    Fortschr Med; 1974 Aug; 92(22):906-9. PubMed ID: 4153689
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with using amedin in children with movement disorders of extrapyramidal and labyrinth origin].
    Panfilova ZP; Kaganova ED; Skubak VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(10):1495-7. PubMed ID: 716725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Lindvall B; Olsson JE
    Adv Neurol; 1990; 53():117-22. PubMed ID: 1700581
    [No Abstract]   [Full Text] [Related]  

  • 19. Dystonic seizures induced by movement.
    Hishikawa Y; Furuya E; Yamamoto J; Nan'no H
    Arch Psychiatr Nervenkr (1970); 1973 May; 217(2):113-38. PubMed ID: 4712177
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stereotaxic operations on the brain].
    Kessel FK
    Ther Ggw; 1974 May; 113(5):738-53. PubMed ID: 4603845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.